Altre lingue Anatara Lifesciences Ltd

Azioni

ANR

AU000000ANR0

Tempo differito Australian S.E. Altri mercati azionari 04:27:14 24/04/2024			Variaz. 5gg	Var. 1 gen.
0,046 ^AUD	+6,98%		+9,52%	+109,09%

09/04	Anatara Lifesciences inizia il reclutamento per la seconda fase dello studio sulla sindrome dell'intestino irritabile	MT
28/02	Anatara Lifesciences Ltd riporta i risultati degli utili per il semestre conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Anatara Lifesciences Begins Recruitment for Irritable Bowel Syndrome Stage Two Trial	09/04
Anatara Lifesciences Ltd Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
Anatara Lifesciences Raised Nealy AU$960,000 Via Entitlement Offer	08/12
Anatara Lifesciences Limited Webinar on the Company's Stage 1 Irritable Bowel Syndrome	18/10/23
Anatara Lifesciences Limited (ASX:ANR) Webinar on the Company's Stage 1 Irritable Bowel Syndrome	18/10/23
Anatara Lifesciences Ltd Announces Board Changes	01/10/23
Anatara Lifesciences to Proceed to Stage II of IBS Drug Trial	28/09/23
Anatara Lifesciences Finalizes Patients for Irritable Bowel Syndrome Clinical Trial Stage One	31/08/23
Anatara Lifesciences Ltd Reports Earnings Results for the Full Year Ended June 30, 2023	24/08/23
Anatara Lifesciences Receives R&D Tax Rebate; Shares Up 3%	14/08/23
Anatara Lifesciences Ltd Announces Registered Office Change	20/04/23
Anatara Lifesciences Provides Update on the Gastrointestinal Reprogramming(Garp) Trial for IBS	09/03/23
Anatara Lifesciences Ltd Reports Earnings Results for the Half Year Ended December 31, 2022	23/02/23
Anatara Lifesciences Ltd Announces board Changes	06/12/22
Anatara Lifesciences Raising Funds for Patient Trial, Future Project Acquisitions	21/10/22
Anatara Lifesciences Receives More than $310,000 R&D Tax Rebate	05/10/22
CSIRO Halts Psychological Functioning Trial for Dietary Supplement	03/10/22
Anatara Lifesciences Limited Provides Updates on 3FDC Clinical Trial	02/10/22
Anatara Lifesciences Limited Reports Earnings Results for the Full Year Ended June 30, 2022	29/08/22
Anatara Lifesciences Modifies Protocol for Upccoming Gastrointestinal Disease Trial	11/08/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Anatara Lifesciences Ltd

Azioni

ANR

AU000000ANR0

Altre lingue

Filtri